Table 1 Clinicopathologic features of 65 ovarian cancer patients.
From: A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients
Total | 65 | |
|---|---|---|
Age | Median (range) | 54 (33–84) |
TMB | Median (range) | 4.1 (0.6–23.2) |
Tumor site | Primary lesion | 49 (75.38%) |
Metastatic lesion | 10 (15.38%) | |
Unknown | 6 (9.23%) | |
Histology | High-grade serous adenocarcinoma | 50 (76.92%) |
Low-grade serous adenocarcinoma | 6 (9.23%) | |
Mucinous adenocarcinoma | 1 (1.54%) | |
Clear cell tumor | 1 (1.54%) | |
Endometrioid tumor | 1 (1.54%) | |
Unknown | 6 (9.23%) | |
Tumor stage | Stage I | 5 (7.69%) |
Stage II | 8 (12.31%) | |
Stage III | 35 (53.85%) | |
Stage IV | 9 (13.85%) | |
Unknown | 8 (12.31%) | |
Tumor differentiation | Well/moderately differentiated | 4 (6.15%) |
Poorly/undifferentiated | 53 (81.54%) | |
Unknown | 8 (12.31%) |
